Published in Am J Psychiatry on April 01, 1982
Thyroid functions and bipolar affective disorder. J Thyroid Res (2011) 1.00
Cocaine and other stimulants. Actions, abuse, and treatment. N Engl J Med (1988) 3.98
Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev (2001) 1.90
Hypercortisolemia and hippocampal changes in depression. Psychiatry Res (1993) 1.52
Self-inflicted gunshot wounds: lethality of method versus intent. Am J Psychiatry (1985) 1.50
Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. Arch Gen Psychiatry (1992) 1.41
Hippocampal abnormalities in depression. J Neuropsychiatry Clin Neurosci (1991) 1.19
Narcotic addiction among physicians: a ten-year follow-up. Am J Psychiatry (1966) 1.18
Neuroanatomical substrates of depression in the elderly. Eur Arch Psychiatry Clin Neurosci (1993) 1.17
Pituitary size in depression. J Clin Endocrinol Metab (1991) 1.16
Amphetamine stereotypy: the influence of environmental factors and prepotent behavioral patterns on its topography and development. Biol Psychiatry (1975) 1.10
Rating the behavioral effects of amphetamine. Eur J Pharmacol (1974) 1.08
Assault and homicide associated with amphetamine abuse. Am J Psychiatry (1971) 1.05
Evolving behavior in the clinical and experimental amphetamine (model) psychosis. Am J Psychiatry (1973) 1.01
Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam. Psychopharmacology (Berl) (1985) 1.01
Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam. J Pharmacokinet Biopharm (1990) 1.00
Cocaine dependence. Annu Rev Med (1989) 1.00
Effects of marijuana on performance of a computerized cognitive-neuromotor test battery. Psychiatry Res (1994) 1.00
Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry (1988) 0.99
Auditory habituation at primary cortex as a function of stimulus rate. Exp Neurol (1968) 0.94
Modeling the pharmacokinetics and pharmacodynamics of dexamethasone in depressed patients. Eur J Clin Pharmacol (1992) 0.94
Fundamental mechanisms underlying altered behavior following chronic administration of psychomotor stimulants. Biol Psychiatry (1980) 0.92
Posterior fossa abnormalities in major depression: a controlled magnetic resonance imaging study. Acta Psychiatr Scand (1992) 0.92
Stimulants: interaction with clinically relevant drugs. Ann N Y Acad Sci (1976) 0.91
Differential time-course profiles of dopamine release and uptake changes induced by three dopamine uptake inhibitors. Synapse (2001) 0.90
Intermittent and continuous cocaine administration: residual behavioral states during withdrawal. Pharmacol Biochem Behav (1992) 0.89
Alcohol pharmacodynamics in young-elderly adults contrasted with young and middle-aged subjects. Psychopharmacology (Berl) (1995) 0.89
MR assessment of pituitary gland morphology in healthy volunteers: age- and gender-related differences. AJNR Am J Neuroradiol (1992) 0.89
In vivo assessment of pituitary gland volume with magnetic resonance imaging: the effect of age. J Clin Endocrinol Metab (1990) 0.89
Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment. Psychopharmacology (Berl) (1996) 0.88
Forgetting rates for verbal, pictorial, and figural stimuli. J Clin Exp Neuropsychol (1993) 0.88
In vivo stereological assessment of caudate volume in man: effect of normal aging. Life Sci (1990) 0.88
Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects. J Neuropsychiatry Clin Neurosci (1991) 0.88
In vivo stereological assessment of human cerebellar volume: effects of gender and age. AJNR Am J Neuroradiol (1991) 0.86
Amphetamine psychosis. II. Theoretical implications. Int J Neuropsychiatry (1968) 0.86
Cocaine-mediated impairment of cardiac conduction in the dog: a potential mechanism for sudden death after cocaine. J Pharmacol Exp Ther (1990) 0.85
Therapeutic effects of antidepressants in chronic pain. Gen Hosp Psychiatry (1984) 0.85
Chronic D-amphetamine in nucleus accumbens: lack of tolerance or reverse tolerance of locomotor activity. Life Sci (1981) 0.85
In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. Psychiatry Res (1992) 0.85
A brain magnetic resonance imaging study of pituitary gland morphology in anorexia nervosa and bulimia. Biol Psychiatry (1990) 0.84
Augmentation of the behavioral and electrophysiologic response to cocaine by chronic administration in the rat. Exp Neurol (1977) 0.84
Methamphetamine self-administration in the cat. Psychopharmacologia (1976) 0.84
Reverse tolerance to stimulant-induced abnormal behavior. Life Sci (1977) 0.84
Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides. Neuroscience (1997) 0.83
Cerebral atrophy in bulimia. Biol Psychiatry (1989) 0.82
Effect of cocaine, nomifensine, GBR 12909 and WIN 35428 on carbon fiber microelectrode sensitivity for voltammetric recording of dopamine. J Neurosci Methods (2000) 0.82
The effects of chronic cocaine pretreatment on kindled seizures and behavioral stereotypies. Exp Neurol (1979) 0.82
Alterations in baseline activity and quinpirole sensitivity in putative dopamine neurons in the substantia nigra and ventral tegmental area after withdrawal from cocaine pretreatment. Neuropsychopharmacology (1998) 0.82
Potentiation of the behavioral and convulsant effects of cocaine by chronic administration in the rat. Pharmacol Biochem Behav (1977) 0.82
Profile of acute tolerance to three sedative anxiolytics. Psychopharmacology (Berl) (1983) 0.82
Cardiac presentation of Munchausen's syndrome. Psychosomatics (1980) 0.81
Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine. Psychopharmacology (Berl) (1997) 0.81
Combining 'caged-dopamine' photolysis with fast-scan cyclic voltammetry to assess dopamine clearance and release autoinhibition in vitro. J Neurosci Methods (1996) 0.81
Behavioral analysis of chronic amphetamine intoxication. Biol Psychiatry (1972) 0.81
Residency training in the psychiatric emergency room. Am J Psychiatry (1982) 0.81
Central nervous system cytopathological changes in cats with chronic methedrine intoxication. Brain Res (1970) 0.81
Emergency department patterns in psychiatric visits during the holiday season. Ann Emerg Med (1994) 0.81
Tricyclic-induced akathisia in patients taking conjugated estrogens. Am J Psychiatry (1984) 0.81
Recurrent severe traumatic brain injury. Series of six cases. Am J Phys Med Rehabil (1991) 0.81
Acute deleterious effects of cocaine on cardiac conduction, hemodynamics, and ventricular fibrillation threshold: effects of interaction with a selective dopamine D1 antagonist SCH 39166. J Cardiovasc Pharmacol (1998) 0.81
Neuropsychiatric complications in head injury. Adv Psychosom Med (1986) 0.80
Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder. Biol Psychiatry (1991) 0.80
Subcortical brain anatomy in anorexia and bulimia. Biol Psychiatry (1992) 0.80
Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist. Eur J Pharmacol (2000) 0.80
Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function. J Pharmacol Exp Ther (1994) 0.80
Altered cocaine potency in the nucleus accumbens following 7-day withdrawal from intermittent but not continuous treatment: voltammetric assessment of dopamine uptake in the rat. Psychopharmacology (Berl) (1998) 0.79
Conditioned aversion to a preferred solution following methamphetamine injections. Psychopharmacologia (1973) 0.79
Dopamine efflux during withdrawal from continuous or intermittent cocaine. Psychopharmacology (Berl) (1993) 0.79
Continuous or intermittent cocaine administration: effects of amantadine treatment during withdrawal. Pharmacol Biochem Behav (1994) 0.79
Altered sensitivity of dopamine autoreceptors in rat accumbens 1 and 7 days after intermittent or continuous cocaine withdrawal. Brain Res Bull (2000) 0.79
MRI of corpus callosum and septum pellucidum in depression. Biol Psychiatry (1991) 0.79
Phase I studies of recombinant interferon-gamma. J Biol Response Mod (1990) 0.79
Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine. Psychopharmacology (Berl) (1998) 0.79
Direct, real-time assessment of dopamine release autoinhibition in the rat caudate-putamen. Neuroscience (2002) 0.78
Morphometric changes of the human midbrain with normal aging: MR and stereologic findings. AJNR Am J Neuroradiol (1992) 0.78
MRI scans in patients with tardive dyskinesia. Biol Psychiatry (1988) 0.78
Age-related increase in CNS sensitivity to benzodiazepines as assessed by task difficulty. Psychopharmacology (Berl) (1990) 0.78
Neuroanatomical changes and hypothalamo-pituitary-adrenal axis abnormalities. Biol Psychiatry (1989) 0.78
Conditioned aversion in spatial paradigms following methamphetamine injection. Psychopharmacologia (1974) 0.78
Influence of gamma-butyrolactone on behavior due to dopaminergic drugs. Physiol Behav (1983) 0.78
Effect of cocaine on dopamine transporter receptors depends on routes of chronic cocaine administration. Neuropsychopharmacology (1996) 0.78
Cerebral atrophy in anorexia nervosa: a pilot study. Biol Psychiatry (1989) 0.78
Psychotropic drugs promoting weight gain: health risks and treatment implications. South Med J (1983) 0.78
Comparative pharmacodynamics of benzodiazepines. Psychopharmacol Ser (1987) 0.78
Effects of single and repeated alcohol withdrawal on kindling. Biol Psychiatry (1984) 0.78
Discriminative stimulus properties of psychomotor stimulants in the cat. Psychopharmacology (Berl) (1979) 0.78
Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine. Mol Pharmacol (1994) 0.77
Aging of the human corpus callosum: magnetic resonance imaging in normal volunteers. J Neuropsychiatry Clin Neurosci (1991) 0.77
Narcotic addicts in the mid-1960's. Public Health Rep (1966) 0.77
The effects of continuous cocaine dose on the induction of behavioral tolerance and dopamine autoreceptor function. Eur J Pharmacol (1999) 0.77
Brain T1 measured by magnetic resonance imaging in bulimia. Biol Psychiatry (1990) 0.77
Withdrawal from continuous or intermittent cocaine: effects of NAN-190 on cocaine-induced locomotion. Pharmacol Biochem Behav (1993) 0.77
Habituation of evoked response to uniaural clicks. Brain Res (1968) 0.77
Quaalude alley: a one-way street. Am J Psychiatry (1973) 0.77
Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam. Psychopharmacology (Berl) (1997) 0.77
Blockade of accumbens 5-HT3 receptor down-regulation by ondansetron administered during continuous cocaine administration. Eur J Pharmacol (1999) 0.77
Technique for the continuous infusion of high doses of cocaine by osmotic minipump. Pharmacol Biochem Behav (1993) 0.77
Cholinergic modulation of stimulant-induced behavior. Pharmacol Biochem Behav (1984) 0.77
Amphetamine abuse. Science (1971) 0.76
Tolerance to cocaine-induced convulsions in the cat. Eur J Pharmacol (1978) 0.76
Behavior and histopathological findings during chronic methedrine intoxication. Biol Psychiatry (1970) 0.76